Use of Extracellular Vesicles (EV) for Diabetic Foot Ulcers

Diabetes Mellitus is a common chronic medical condition that requires complex care strategies. Treatment includes methods to reduce glycemic burden and maintain glycemic control in the patient to prevent symptoms of hyperglycemia and reduce microvascular complications. In the case of patients with diabetes mellitus, wound healing, skin re- epithelization and skin integrity restoration are compromised, leading to chronic cutaneous ulcers such as diabetic foot ulcers. As much as 15% of all diabetic patients manifest diabetic foot ulcers. Moreover, 84% of all diabetes related lower leg amputations are anticipated to the result of diabetic foot ulcers. Compromised chronic cutaneous ulcer healing may result from cytokines, growth factor deficits, and insufficient angiogenesis process.

NCT Number	NCT06825884
Lead Sponsor	University of Jordan Collaborators: Abdalla Awidi Abbadi, MD
Conditions	Diabetic Foot Ulcer
Enrollment	10 participants
Start Date	2024-12-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-01-31 (estimated)
Updated on ClinicalTrials.gov	2025-04-16